NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/10/2022
Voltar para busca
Dado oficial do USPTO
MIURON
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
21/04/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35
Data de depósito
02/12/2020
Data de registro
04/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/10/2022
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
SEOUL, KR
Examinador
HUTCHISON, DAVID
Unidade examinadora
N50
Localização atual
PETITIONS OFFICE
Titulares e representantes
Titulares
YIPSCELL INC.
YIPSCELL INC.
CiSTEM Inc.
Representantes
minchul yang STIP LAW GROUP LLC
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the treatment of cells; living cells for veterinary purposes; stem cells for veterinary purposes; cytostatics for pharmaceutical purposes; living cells for medical purposes; cellular function activating agents for medical purposes; cytostatics for medical purposes; stem cells for medical purposes; stem cells for pharmaceutical purposes; implantable textile material to encourage the growth of tissue; surgical implants grown from stem cells being living tissues; Biological implants comprised of living tissue for guided tissue regeneration; implantable materials for use in guided tissue regenerationbiological tissue grafts; reagents for use in medical genetic testing; cultures of microorganisms for medical purposes; medical adhesives for binding internal tissue; medical and surgical plasters; Pharmaceutical preparations for chondrocyte treatments using induced pluripotent stem cells
Classe 35
Wholesale store services featuring stem cells for scientific purposes; Wholesale store services featuring stem cells for research purposes; Wholesale store services featuring living cells for veterinary purposes; Wholesale store services featuring stem cells for veterinary purposes; Wholesale store services featuring cytostatics for pharmaceutical purposes; Wholesale store services featuring living cells for medical purposes; Wholesale store services featuring cells for medical purposes; Wholesale store services featuring cellular function activating agents for medical purposes; Wholesale store services featuring cytostatics for medical purposes; Wholesale store services featuring stem cells for medical purposes; Wholesale store services featuring stem cells; Wholesale store services featuring surgical implants grown from stem cells being living tissues; Wholesale store services featuring surgical implants grown from stem cells; Wholesale store services featuring cellchip inspectors; Wholesale store services featuring incubators for cell culture; Wholesale store services featuring apparatus for the regeneration of stem cells for medical purposes; Wholesale store services featuring pharmaceutical preparations for the treatment of cells; Retail store services featuring pharmaceutical preparations for the treatment of cells; Business intermediary services relating to the purchase and sale of pharmaceutical preparations for the treatment of cells; Wholesale store services featuring chondrocyte treatment products using induced pluripotent stem cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
04/10/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE
08/08/2022
APET
ASSIGNED TO PETITION STAFF
03/08/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
19/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/07/2022
PUBO
PUBLISHED FOR OPPOSITION
19/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/06/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
27/05/2022
GNFR
FINAL REFUSAL E-MAILED
27/05/2022
CNFR
FINAL REFUSAL WRITTEN
27/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/05/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
23/05/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/05/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
28/03/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
28/03/2022
CNSI
SUSPENSION INQUIRY WRITTEN
28/03/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/09/2021
GNSL
LETTER OF SUSPENSION E-MAILED
28/09/2021
CNSL
SUSPENSION LETTER WRITTEN
28/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/09/2021
ALIE
ASSIGNED TO LIE
16/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/03/2021
GNRT
NON-FINAL ACTION E-MAILED
21/03/2021
CNRT
NON-FINAL ACTION WRITTEN
21/03/2021
DOCK
ASSIGNED TO EXAMINER
09/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2021
NWAP
NEW APPLICATION ENTERED
05/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MIURON ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.